ABT
Price
$110.83
Change
+$1.75 (+1.60%)
Updated
Feb 6 closing price
Capitalization
192.72B
73 days until earnings call
Intraday BUY SELL Signals
ARAY
Price
$0.62
Change
+$0.02 (+3.33%)
Updated
Feb 6 closing price
Capitalization
70.27M
87 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABT vs ARAY

Header iconABT vs ARAY Comparison
Open Charts ABT vs ARAYBanner chart's image
Abbott Laboratories
Price$110.83
Change+$1.75 (+1.60%)
Volume$9.92M
Capitalization192.72B
Accuray
Price$0.62
Change+$0.02 (+3.33%)
Volume$1.7M
Capitalization70.27M
ABT vs ARAY Comparison Chart in %
View a ticker or compare two or three
VS
ABT vs. ARAY commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a StrongBuy and ARAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (ABT: $110.83 vs. ARAY: $0.62)
Brand notoriety: ABT: Notable vs. ARAY: Not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ABT: 107% vs. ARAY: 163%
Market capitalization -- ABT: $192.72B vs. ARAY: $70.27M
ABT [@Medical/Nursing Services] is valued at $192.72B. ARAY’s [@Medical/Nursing Services] market capitalization is $70.27M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $192.72B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABT’s FA Score shows that 1 FA rating(s) are green whileARAY’s FA Score has 0 green FA rating(s).

  • ABT’s FA Score: 1 green, 4 red.
  • ARAY’s FA Score: 0 green, 5 red.
According to our system of comparison, ABT is a better buy in the long-term than ARAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABT’s TA Score shows that 6 TA indicator(s) are bullish while ARAY’s TA Score has 4 bullish TA indicator(s).

  • ABT’s TA Score: 6 bullish, 3 bearish.
  • ARAY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ABT is a better buy in the short-term than ARAY.

Price Growth

ABT (@Medical/Nursing Services) experienced а +1.40% price change this week, while ARAY (@Medical/Nursing Services) price change was -23.20% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.74%. For the same industry, the average monthly price growth was -3.74%, and the average quarterly price growth was +10.59%.

Reported Earning Dates

ABT is expected to report earnings on Apr 22, 2026.

ARAY is expected to report earnings on May 06, 2026.

Industries' Descriptions

@Medical/Nursing Services (-3.74% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABT($193B) has a higher market cap than ARAY($70.3M). ABT YTD gains are higher at: -11.093 vs. ARAY (-24.812). ABT has higher annual earnings (EBITDA): 11.8B vs. ARAY (7.67M). ARAY has less debt than ABT: ARAY (179M) vs ABT (12.9B). ABT has higher revenues than ARAY: ABT (43.8B) vs ARAY (451M).
ABTARAYABT / ARAY
Capitalization193B70.3M274,538%
EBITDA11.8B7.67M153,866%
Gain YTD-11.093-24.81245%
P/E Ratio29.79N/A-
Revenue43.8B451M9,712%
Total CashN/A63.3M-
Total Debt12.9B179M7,207%
FUNDAMENTALS RATINGS
ABT vs ARAY: Fundamental Ratings
ABT
ARAY
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
83100
SMR RATING
1..100
3097
PRICE GROWTH RATING
1..100
6494
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABT's Valuation (50) in the Medical Specialties industry is in the same range as ARAY (50). This means that ABT’s stock grew similarly to ARAY’s over the last 12 months.

ABT's Profit vs Risk Rating (83) in the Medical Specialties industry is in the same range as ARAY (100). This means that ABT’s stock grew similarly to ARAY’s over the last 12 months.

ABT's SMR Rating (30) in the Medical Specialties industry is significantly better than the same rating for ARAY (97). This means that ABT’s stock grew significantly faster than ARAY’s over the last 12 months.

ABT's Price Growth Rating (64) in the Medical Specialties industry is in the same range as ARAY (94). This means that ABT’s stock grew similarly to ARAY’s over the last 12 months.

ABT's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as ARAY (100). This means that ABT’s stock grew similarly to ARAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABTARAY
RSI
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
47%
Bullish Trend 3 days ago
72%
Momentum
ODDS (%)
Bullish Trend 3 days ago
57%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
48%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
52%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
51%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
52%
Bullish Trend 10 days ago
73%
Declines
ODDS (%)
Bearish Trend 5 days ago
52%
Bearish Trend 6 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
53%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 3 days ago
52%
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ABT
Daily Signal:
Gain/Loss:
ARAY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EDC70.545.21
+7.97%
Direxion Daily MSCI Em Mkts Bull 3X ETF
MSOS4.160.19
+4.79%
AdvisorShares Pure US Cannabis ETF
SCHF25.970.58
+2.28%
Schwab International Equity ETF™
FTDS62.670.86
+1.40%
First Trust Dividend Strength ETF
AAPW40.470.12
+0.30%
Roundhill AAPL WeeklyPay ETF

ABT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABT has been loosely correlated with TMCI. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then TMCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
+1.60%
TMCI - ABT
65%
Loosely correlated
+10.78%
ARAY - ABT
59%
Loosely correlated
+3.32%
OM - ABT
55%
Loosely correlated
+2.51%
ITGR - ABT
53%
Loosely correlated
+1.43%
RBOT - ABT
52%
Loosely correlated
+6.49%
More